Shares of AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $5.40 and traded as high as $7.54. AIkido Pharma shares last traded at $7.42, with a volume of 325,818 shares trading hands.
AIkido Pharma Price Performance
The firm has a market cap of $40.70 million, a P/E ratio of -1.91 and a beta of 0.93. The stock’s 50-day simple moving average is $6.31 and its two-hundred day simple moving average is $5.40.
AIkido Pharma Company Profile
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
See Also
- Five stocks we like better than AIkido Pharma
- Large Cap Stock Definition and How to Invest
- Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally
- The Most Important Warren Buffett Stock for Investors: His Own
- Let the Good Times Roll: 2 Stocks Showing No Signs of Slowing
- Retail Stocks Investing, Explained
- Café Culture Revival? 3 Stocks to Watch After Chick-fil-A’s Move
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
